These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32195944)

  • 21. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
    Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
    Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary malignant lymphoma of the testis].
    Stein M; Haim N; Ben-Shahar M; Epelbaum R; Cohen Y; Ben Arie J; Robinson E
    Harefuah; 1991 Feb; 120(3):125-8. PubMed ID: 2032640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype.
    Li D; Xie P; Mi C
    Pathol Res Pract; 2010 Sep; 206(9):611-5. PubMed ID: 20627604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
    Hori Y; Yamamoto H; Nozaki Y; Torisu T; Fujiwara M; Taguchi K; Nishiyama K; Nakamura S; Kitazono T; Oda Y
    Hum Pathol; 2020 Feb; 96():67-78. PubMed ID: 31734190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diffuse large B-cell lymphoma of testis: a clinicopathologic and immunophenotypic study of 58 cases].
    Yang ZR; Bi CF; Zhang WY; Yang QP; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):589-92. PubMed ID: 24314243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphoma of the testis as primary location: tumour review.
    Koukourakis G; Kouloulias V
    Clin Transl Oncol; 2010 May; 12(5):321-5. PubMed ID: 20466616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
    Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.
    Miles RR; Raphael M; McCarthy K; Wotherspoon A; Lones MA; Terrier-Lacombe MJ; Patte C; Gerrard M; Auperin A; Sposto R; Davenport V; Cairo MS; Perkins SL;
    Pediatr Blood Cancer; 2008 Sep; 51(3):369-74. PubMed ID: 18493992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary testicular lymphoma.
    Vitolo U; Ferreri AJ; Zucca E
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):183-9. PubMed ID: 17962036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.
    van der Meeren LE; Kluiver J; Rutgers B; Alsagoor Y; Kluin PM; van den Berg A; Visser L
    PLoS One; 2019; 14(10):e0223260. PubMed ID: 31603917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathologic features and expression of OCT4 protein in testicular diffuse large B cell lymphoma].
    Chen YP; Zhu WF; Chen LF; Lu JP; He TM; Fu WD; Xu CW; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):383-387. PubMed ID: 28591984
    [No Abstract]   [Full Text] [Related]  

  • 34. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma.
    Xu J; Liu JL; Medeiros LJ; Huang W; Khoury JD; McDonnell TJ; Tang G; Schlette E; Yin CC; Bueso-Ramos CE; Lin P; Li S
    Eur J Haematol; 2020 Apr; 104(4):336-343. PubMed ID: 31944390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary testicular presentation of ALK-1-negative anaplastic large cell lymphoma in a pediatric patient.
    Lagmay J; Termuhlen A; Fung B; Ranalli M
    J Pediatr Hematol Oncol; 2009 May; 31(5):330-2. PubMed ID: 19415011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
    Yoon SO; Jeon YK; Paik JH; Kim WY; Kim YA; Kim JE; Kim CW
    Histopathology; 2008 Aug; 53(2):205-17. PubMed ID: 18752503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma].
    Han YS; Xue YQ; Yang HY; Zhang J; Pan JL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):143-7. PubMed ID: 23568722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
    Bedekovics T; Hussain S; Feldman AL; Galardy PJ
    Blood; 2016 Mar; 127(12):1564-74. PubMed ID: 26702068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
    J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EBV
    Liu H; Xu-Monette ZY; Tang G; Wang W; Kim Y; Yuan J; Li Y; Chen W; Li Y; Fedoriw GY; Zhu F; Fang X; Luedke C; Medeiros LJ; Young KH; Hu S
    Histopathology; 2022 Feb; 80(3):575-588. PubMed ID: 34637146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.